| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/23/2009 | US20090104601 Genetic diagnosis using multiple sequence variant analysis |
| 04/23/2009 | US20090104600 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection |
| 04/23/2009 | US20090104596 Noninvasive Measurement and Identification of Biomarkers in Disease State |
| 04/23/2009 | US20090104595 Methods for determining the sensitivity or resistance of retrovirus isolates to therapeutic retroviral treatments based on viral protease inhibitors and diagnostic kits |
| 04/23/2009 | US20090104500 Proton Conductors |
| 04/23/2009 | US20090104279 Use of pak inhibitor for the treatment of a joint disease |
| 04/23/2009 | US20090104277 Preparation of Molecular Imprinted Polymers |
| 04/23/2009 | US20090104230 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/23/2009 | US20090104220 Method to Make a Peptide-Carrier Conjugate with a High Immunogenicity |
| 04/23/2009 | US20090104208 House Dust Mite Allergen |
| 04/23/2009 | US20090104204 Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof |
| 04/23/2009 | US20090104202 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
| 04/23/2009 | US20090104201 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 04/23/2009 | US20090104199 Breast Cancer Resistance Protein (BCRP) And The DNA Which Encodes It |
| 04/23/2009 | US20090104197 vWFA and/or ANT_IG Domain Containing Proteins |
| 04/23/2009 | US20090104196 for modulating the activity of the lysine-specific demethylase (LSD1) in a mammal; for identifying a patient having high risk prostate carcinomas |
| 04/23/2009 | US20090104195 Targeted ligands |
| 04/23/2009 | US20090104193 SEMA4D in Cancer Diagnosis, Detection and Treatment |
| 04/23/2009 | US20090104192 Monoclonal Antibodies to Hepatocyte Growth Factor |
| 04/23/2009 | US20090104189 Neutrokine-alpha and neutrokine-alpha splice variant |
| 04/23/2009 | US20090104188 Anti-hepatitis c virus antibody and uses thereof |
| 04/23/2009 | US20090104185 Methods and Compositions for Mycoplasma Toxins |
| 04/23/2009 | US20090104182 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 04/23/2009 | US20090104181 Antibodies for Discrimination of Prions |
| 04/23/2009 | US20090104147 Sialoadhesin-Related Compositions and Methods |
| 04/23/2009 | US20090104122 DETECTION OF MEMBRANE ANDROGEN RECEPTOR (mAR) AGENTS |
| 04/23/2009 | US20090104121 Multi-subunit biological complexes for treatment of plaque-associated diseases |
| 04/23/2009 | US20090104120 Dlx1 cancer markers |
| 04/23/2009 | US20090104115 Cancerous disease modifying antibodies |
| 04/23/2009 | US20090104080 suspending reaction drops, forced microconvection |
| 04/23/2009 | US20090103091 interferometric detection system and method |
| 04/23/2009 | US20090103086 Portable sample preparation and analysis system for micron and sub-micron particle characterization using light scattering and absorption spectroscopy |
| 04/23/2009 | US20090102387 Solar powered light assembly to produce light of varying colours |
| 04/23/2009 | US20090101996 Nanostructures with electrodeposited nanoparticles |
| 04/23/2009 | US20090101599 Methods And Apparatus For Isolating Platelets From Blood |
| 04/23/2009 | US20090101506 Method, specific primers and kit for the detection of neisseria meningitidis |
| 04/23/2009 | US20090101165 Apparatus for Detection of Chemical or Biological Substances and Method for Cleaning the Apparatus |
| 04/23/2009 | US20090101060 Dip and see sugar indicator |
| 04/23/2009 | US20090100946 Secure resource tracker |
| 04/23/2009 | US20090100937 Method of grading microfiber cleaning cloths |
| 04/23/2009 | US20090100915 Method of Sampling Specimen, Test Method and Dropping Pipette and Specimen Sampler to be Used Therein |
| 04/23/2009 | US20090100912 Process For Evaluating Fouling Caused By Refinery Feedstocks |
| 04/23/2009 | US20090100911 Method for producing synthetic resin mold package, alcohol concentration sensor and apparatus for measuring alcohol concentration |
| 04/23/2009 | US20090100907 Gas sensor |
| 04/23/2009 | US20090100906 Phased micro analyzer viii |
| 04/23/2009 | US20090100905 Process for Treating Perfluorides |
| 04/23/2009 | US20090100898 System, apparatus and method for dispensing chemical vapor |
| 04/23/2009 | DE10339905B4 Implantierbarer Mikrozellprozessor zur Krankheitsbehandlung The implantable micro cell processor for disease treatment |
| 04/23/2009 | DE102008051846A1 Recirculation exhaust gas sampling system for internal combustion engine i.e. diesel type combustion engine, has distributor devices to transmit gas utilized as sample to analyzing systems for analyzing compositions and/or components of gas |
| 04/23/2009 | DE102008047762A1 Biosensor mit Transistorkanal im Nanobereich Biosensor with transistor channel at the nanoscale |
| 04/23/2009 | DE102008046746A1 Virtueller Kraftstoffsensor für Doppelkraftstofftankanwendungen Virtual fuel sensor for dual fuel tank applications |
| 04/23/2009 | DE102007010879B4 Sensor und Verfahren zur Bestimmung der Sauerstoffversorgung in der Wurzel Sensor and method for determining the oxygen supply in the root |
| 04/23/2009 | CA2745309A1 A diagnostic device for identifying rupture of membrane during pregnancy |
| 04/23/2009 | CA2740882A1 Use of ps20/wfdc1 and interferons to diagnose, monitor and treat viral diseases |
| 04/23/2009 | CA2740845A1 Estimating detailed compositional information from limited analytical data |
| 04/23/2009 | CA2703112A1 Method and apparatus for identifying and tracking biological fluid |
| 04/23/2009 | CA2703050A1 Anti-amyloid antibodies, compositions, methods and uses |
| 04/23/2009 | CA2703026A1 Prognostic molecular markers for et-743 treatment |
| 04/23/2009 | CA2702939A1 Anti-bst2 antibody |
| 04/23/2009 | CA2702880A1 Antibody capable of specifically binding to a beta oligomer, and use thereof |
| 04/23/2009 | CA2702655A1 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof |
| 04/23/2009 | CA2702653A1 Diagnostic, predictive and prognostic testing for cancer |
| 04/23/2009 | CA2702617A1 Immunotherapy regimes dependent on apoe status |
| 04/23/2009 | CA2702582A1 Feline pancreatic lipase |
| 04/23/2009 | CA2702533A1 Edta resistant s100a12 complexes (erac) |
| 04/23/2009 | CA2702376A1 Markers of matrix gene expression and cellular differentiation in chondrocytes |
| 04/23/2009 | CA2701693A1 Method and system for measurement of electrical stability of fluids |
| 04/23/2009 | CA2701163A1 Knockout mice for a p450 gene cluster |
| 04/23/2009 | CA2696227A1 Dissolution rate verification |
| 04/23/2009 | CA2695460A1 Phenobarbital derivatives useful in immunoassay |
| 04/23/2009 | CA2660805A1 Improved gas analyzer |
| 04/22/2009 | EP2051177A1 Method for the prediction of molecular interaction networks |
| 04/22/2009 | EP2051147A2 Method of producing functional service areas on a flat substrate |
| 04/22/2009 | EP2051080A1 D/p creatinine marker, method of determining d/p creatinine and use of the same |
| 04/22/2009 | EP2051079A2 Annexins as markers for lung or esophageal cancer |
| 04/22/2009 | EP2051078A1 Method and marker for diagnosing diabetes mellitus |
| 04/22/2009 | EP2051077A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 04/22/2009 | EP2051076A1 Interaction of probe molecules and cells as a diagnostic marker |
| 04/22/2009 | EP2051075A1 Particles |
| 04/22/2009 | EP2051074A1 Sample device preservation |
| 04/22/2009 | EP2051073A1 Methods and kits for predicting risk for preterm labor |
| 04/22/2009 | EP2051072A2 Test strip identification function and test instrument using the same |
| 04/22/2009 | EP2051068A2 Humidity Control Apparatus for Electrochemical Sensors |
| 04/22/2009 | EP2051066A1 Method of, and apparatus for, detecting of any interaction between nucleic acid and protein |
| 04/22/2009 | EP2050827A2 Differentially Expressed Tumour-specific Polypeptides for use in the Diagnosis and Treatment of Cancer |
| 04/22/2009 | EP2050825A1 Method of preparing a standard diagnostic gene transcript pattern |
| 04/22/2009 | EP2050824A1 Electrochemical method for detecting hemoglobin or hematocrit and test strip thereof |
| 04/22/2009 | EP2050822A1 Hepatitis C virus replicons and replicon enhanced cells |
| 04/22/2009 | EP2050762A2 Novel polypeptides and nucleic acids encoding the same |
| 04/22/2009 | EP2050761A1 Galactosylated peptides, their preparation and use in autoimmune diseases diagnosis |
| 04/22/2009 | EP2050466A1 Diagnosis and treatment of cancer using anti-desmoglein-3 antibody |
| 04/22/2009 | EP2050463A2 Vaccine compositon for vaccinating dogs against canine infectious respiratory disease (CIRD) |
| 04/22/2009 | EP2050335A1 Gene disruptions, compositions and methods relating thereto |
| 04/22/2009 | EP2050035A2 Methods for identifying, diagnosing, and predicting survival of lymphomas |
| 04/22/2009 | EP2050027A2 Crystal structure of p53 mutants and their use |
| 04/22/2009 | EP2049906A1 Assay and kit for predicting implantation success in assisted fertilisation |
| 04/22/2009 | EP2049905A1 Use of nnmt as a marker for lung cancer |
| 04/22/2009 | EP2049904A1 Use of melanoma inhibitory activity (mia) protein as an early indicator for therapeutic response in melanoma |
| 04/22/2009 | EP2049903A2 An immunochromatography device for the diagnosis of diseases in a sample |
| 04/22/2009 | EP2049902A2 Devices and methods for performing receptor binding assays using magnetic particles |